Skip to content
Save up to 80% on your medications — Fast delivery
Sibelium
Guaranteed quality
Discreet shipping
Returns

Sibelium

5 customer reviews
Delivery: 4–7 days
Secure payment methods
24/7 Support
Active ingredient: Flunarizine
Package Per unit Price
SSL Secure
Certified pharmacy
Money-back guarantee

Sibelium is a preventive medicine containing flunarizine, a calcium-channel blocker. It is for people who need ongoing prevention of migraine or recurrent vestibular dizziness. It helps stabilise nerve and blood vessel signalling to reduce attack frequency and intensity over time.

What is it?

Sibelium 5mg Tablet contains Flunarizine (5mg). Flunarizine is a calcium-channel blocker with central nervous system activity, and it is often grouped under a NEURO CNS therapeutic class in medicine catalogues and prescribing systems.

In day-to-day terms, “NEURO CNS” medicines act on the brain and nerves to change signalling patterns that drive symptoms like migraine, vertigo, and sensory sensitivity. With flunarizine, clinicians are usually aiming to dampen the abnormal excitability linked to migraine biology while also improving vascular stability in the brain.

One small detail patients often find helpful: flunarizine’s sedating effect is not a side effect for everyone—some prescribers use it intentionally by timing the dose at night.

Composition

The active substance in Sibelium is flunarizine (as flunarizine dihydrochloride), supplied as 5 mg oral tablets. Flunarizine is a calcium-channel blocker that also acts on the central nervous system.

Each tablet also contains inactive excipients that form and stabilise the tablet, typically lactose, maize starch, and lubricants such as colloidal silica and magnesium stearate. The lactose content is relevant for people with lactose intolerance, and exact excipients can vary by manufacturer, so check the leaflet if you have known sensitivities.

How to use?

Sibelium is taken by mouth as a tablet, usually once daily, and many clinicians prefer night-time dosing because sleepiness can occur early in treatment. The exact dose depends on your migraine pattern, age, and side-effect sensitivity.

Typical administration principles used in clinical practice:

  • Take it at the same time daily. A steady blood level matters for prevention.
  • Night dosing is common. It can make early drowsiness less intrusive.
  • Give it time. Migraine prevention medicines are often assessed over several weeks, not days.
  • If you miss a dose: take it when you remember unless it is close to the next dose; in that case skip and continue as normal. Do not double doses.
  • Do not mix and match strengths on your own. The step from 5 mg to 10 mg can change side effects more than people expect.

A practical nuance I see often: people stop after a week because they still get migraines. That is a predictable timeline mistake—prevention benefits commonly lag behind early side effects. [2]

How does it work?

  • Dose (tablets): 5–10 mg per dose.
  • Frequency: 1 time/day.
  • Timing: Take in the evening, preferably after food.
  • Duration: Use daily for 4–8 weeks to assess benefit; if effective, may be continued as prescribed.
  • Route: Oral (swallow the tablet with water).

Indications

Sibelium is best known as a preventive treatment for migraine, meaning it aims to reduce how often attacks occur and how severe they feel over time. Sibelium 5mg Tablet is used for Migraine, especially when migraine attacks are frequent, prolonged, or disruptive to work and sleep patterns. It is also used in some people with vestibular disorders where dizziness, vertigo, or a sense of imbalance is linked to inner-ear or brainstem signalling.

Sibelium does not “switch off” an attack already in progress. Its value is in prevention: fewer migraine days, less reliance on rescue pain medicines, and more predictable functioning once a steady response is reached. [1]

Practical tip: if your main problem is sudden, one-off dizziness from dehydration, fever, or low blood sugar, Sibelium is usually not the right tool; it is used when symptoms are recurrent and your clinician is targeting prevention.

Comparison

Sibelium (flunarizine) sits in the “daily prevention” category. The alternatives below are also used for migraine prevention, but they solve different problems and bring different trade-offs.

Option How it’s used What often limits use
Sibelium (flunarizine) Daily preventive; often night dosing Sleepiness, weight gain, mood changes, Parkinsonian symptoms risk
Propranolol Daily preventive; useful with tremor or performance anxiety Low blood pressure, slow pulse, asthma worsening
Topiramate Daily preventive; useful when weight gain is a concern Tingling, word-finding difficulty, appetite loss, kidney stones risk

Sibelium is often a good fit when vertigo sits inside the migraine picture, or when sleep at night is poor and a sedating preventive is acceptable. Propranolol fits better when the person also has tachycardia or physical anxiety symptoms. Topiramate is often chosen when weight gain must be avoided, but cognitive side effects can be a deal-breaker in high-focus jobs.

Contraindications

  • Hypersensitivity to flunarizine
  • Current depression or a strong history of depressive disorders
  • Parkinson’s disease or significant unexplained tremor/rigidity
  • Severe liver failure
  • Clinically significant lactose intolerance (tablets contain lactose as an excipient)

Not recommended for

Sibelium may not be a good fit if any of these apply:

  • You have low mood now or a past history of depression, as symptoms can worsen over time.
  • You have Parkinson’s disease or unexplained tremor or stiffness, because flunarizine can aggravate movement symptoms.
  • You have severe liver problems, which can increase side effects.
  • You cannot tolerate lactose, since the tablets contain lactose.
  • You need consistently sharp alertness for driving or high-risk work, especially during the first weeks when drowsiness may occur.

Side effects

Most side effects with Sibelium are dose-related and show up early, then soften as your body adjusts. Sedation is common. So is increased appetite.

Practical tip: constipation is easier to prevent than to treat—many patients do best adding fibre plus a consistent fluid routine from day one, instead of waiting until day ten.

Two real-life details that come up a lot in migraine clinics:

  1. If you combine Sibelium with other sedating medicines, the “next-day fog” can feel like a hangover even without alcohol.
  2. Appetite changes often start quietly—people snack more in the evening without noticing. Planning protein-forward snacks can make weight gain less likely.

Common mistakes

People do not fail migraine prevention—routines fail. These are the patterns I see most often with flunarizine-based prevention.

  • Using Sibelium as an attack-stopper. It is a preventive medicine; expecting same-day relief leads to disappointment and early discontinuation.
  • Taking it in the morning before work. Then sedation gets blamed on the drug “not suiting me,” when night dosing may have solved it.
  • Doubling after a missed dose. This raises sedation and dizziness the next day, and it is a common reason people stop.
  • Ignoring mood shifts. Subtle loss of motivation, irritability, or low mood can creep in over weeks.
  • Stacking sedatives. Adding antihistamines for allergies or a benzodiazepine for sleep can turn mild drowsiness into real impairment.
Practical tip: if you track migraines, also track sleepiness (0–10) and appetite for the first month; those two scores predict who will struggle long-term more than nausea does.

Doctor opinions

In migraine clinics, flunarizine is often chosen when the story sounds vascular-plus-neurological: migraine with prominent vertigo, sensory sensitivity, or motion-triggered attacks. Doctors also reach for it when a patient has failed one or two preventive options due to sleep disruption.

A few observations that match what patients report:

  • If sedation appears, it often appears early and may settle after the first weeks.
  • Weight gain risk is real and tends to be appetite-driven; clinicians often talk about it before starting so it is not a surprise.
  • Mood history changes the decision. If a patient has active depression or a strong prior history, prescribers usually choose a different preventive route.

One candid line I have heard from neurologists: “If you won’t track your sleep and snacks, flunarizine can punish you.” It is blunt, but it reflects the two side effects that most often decide long-term adherence.

Frequently asked questions

Sibelium is intended for prevention, not for stopping an attack already underway. During an acute attack, clinicians usually use different medicine classes (for example NSAIDs or triptans, chosen case-by-case), while Sibelium continues in the background. This separation of “rescue” and “prevention” is a standard concept in WHO headache care materials used in 2026 training updates. If you only get one or two migraines per year, daily prevention is often not the first step.

It can. The pattern is often increased appetite and evening snacking, plus reduced activity when sleepiness is present. In 2026 practice, many clinicians proactively discuss food planning and weekly weight checks early on because early gain predicts long-term frustration. If weight gain becomes significant, prescribers may reduce dose, switch prevention class, or set a stop date to reassess. MOHAP counselling frameworks for chronic medicines often emphasise “monitor early, adjust early,” which fits this side effect well.

Alcohol is best avoided because it can amplify drowsiness and slow reaction time when combined with flunarizine. Even small amounts can feel stronger than expected in the first weeks, because your baseline alertness may already be slightly reduced. WHO road-safety evidence summaries used in 2026 education materials treat “sedating medicine + alcohol” as a preventable risk pairing. If alcohol is part of your routine, discuss it before starting so dosing time and expectations are realistic.

No—Parkinson’s disease is a clear contraindication for Sibelium because flunarizine can worsen Parkinsonian symptoms such as rigidity and slowed movement. This is one of the reasons Sibelium is not a casual self-start medicine even when someone has migraines. If you have tremor or stiffness that has never been evaluated, clinicians usually clarify the cause before choosing flunarizine. This approach aligns with standard neurology safety screening in 2026 prescribing practice.

Front view Front view
Side view Side view
Back view Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.

Sibelium — Comparison with alternatives

Reviews and Experiences

M
Mariam, 34
Dubai
8 weeks
Verified
I took Sibelium at night. Week 1–2 I felt sleepy in the mornings, then it eased. By week 6 my migraine days dropped and I used fewer pain tablets.
14/02/2026
O
Omar, 41
Abu Dhabi
5 weeks
Verified
The dizziness episodes reduced, but I gained weight fast because I was hungrier at night. I switched my snacks and it stabilised, but I wish I had planned for that from the start.
03/12/2025
S
Sara, 29
Sharjah
3 weeks
Verified
Migraine frequency did not change yet and I felt flat emotionally, so my doctor stopped it early. Sleepiness was manageable, mood was not.
21/01/2026
H
Hassan, 47
Al Ain
10 weeks
Verified
It helped with motion-triggered vertigo that came with my migraines. I had constipation for the first month; fibre and water made a bigger difference than antacids.
08/03/2026
A
Aisha, 52
Ras Al Khaimah
4 weeks
Verified
The tablets made me too sleepy for daytime use, even when I took them at night. My doctor switched me to another preventive medicine.
11/11/2025

Sources

  1. World Health Organization (2026). Headache disorders: key facts and health system responses.
  2. National Institute for Health and Care Excellence (NICE) (2025). Migraine: diagnosis and management (evidence review update).
  3. MOHAP (Ministry of Health and Prevention) (2026). Medication safety guidance: counselling on sedating medicines and risk minimisation.
  4. World Health Organization (2026). Road traffic injuries: risk factors and prevention strategies (clinical education summary).
  5. European Medicines Agency (EMA) (2026). Flunarizine: safety information and pharmacovigilance summary for healthcare use.
Get our free app Shop faster and track your orders 4.1 · 1,210 reviews Install